- Shopping Bag ( 0 items )
From The CriticsReviewer: Paul Hahn, MD, PhD (University of Pennsylvania School of Medicine)
Description: Foremost authorities in the field present a comprehensive examination of various ophthalmologic aspects of diabetes, including historic perspectives, current understanding, and speculation on future directions in this update of an Ophthalmology Monograph originally published in 2000.
Purpose: The purpose is to provide a resource for ophthalmologists, researchers, residents, and medical students. The book presents an overview of systemic diabetes and then focuses on its effects on the eye, with chapters on various aspects including epidemiology, imaging, treatment options, and exciting future therapies. The book is comprehensive and certainly meets the authors' objectives.
Audience: According to the authors, the book is targeted at "ophthalmologists, researchers, as well as residents and medical students" and it is appropriate for this audience.
Features: The book presents a directed exploration of diabetes as it relates to ocular disease. Beginning with an overview of the epidemic of diabetes in a worldwide/systemic setting, the book then focuses its discussion on classification, pathogenesis/histopathology, epidemiology, imaging, and treatment modalities (current and possible future options) for diabetic ocular disease, particularly diabetic retinopathy. The book nicely covers historic perspectives as a means to understand current practice and uses color figures and tables to detail important points. The book is current, relevant, and comprehensive. Specific details, particularly those pertaining to past landmark studies, could have been outlined more extensively, but certainly there is a need to balance detail with brevity, which this book achieves well.
Assessment: This will be extremely useful to any ophthalmologist, concisely providing useful information on current, future, and past therapies communicated by leaders in the field. Undoubtedly, there have been changes in this field, particularly advances in therapies and imaging modalities, and this second edition is a welcome update of the first.